Virtual Self-Management Program for JIA
Launched by UNIVERSITY OF CALGARY · Dec 14, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new online program designed to help teenagers with Juvenile Idiopathic Arthritis (JIA) learn how to manage their condition better. The program includes group sessions over eight weeks where participants will receive education about JIA, learn self-management strategies, and connect with peers who are going through similar experiences. Some teens will join this program right away, while others will be in a control group and will only receive standard care for the time being. After the study, the control group will also have the chance to participate in the program.
To be eligible for this trial, participants need to be between 12 and 17 years old and have been diagnosed with JIA within the last two years. They should also be patients at specific pediatric rheumatology clinics and have internet access to join the online sessions. Participants will complete some surveys before and after the program to help researchers understand its effectiveness. It's important to note that teens with certain other health issues or language barriers may not be able to participate. This program aims to provide valuable support and education to help young people manage their arthritis more effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adolescents between the ages of 12 and 17
- • 2. Confirmed diagnosis within 2 years according to the International League of Associations for Rheumatology JIA classification criteria (2)
- • 3. Followed in one of the pediatric rheumatology clinics participating in the RCT
- • 4. Able to access the Internet on a computer
- • 5. Willing and able to complete online measures
- Exclusion Criteria:
- • 1. Insufficient English reading and speaking skills
- • 2. Untreated psychiatric or comorbid disorders or major cognitive impairments leading to inability to understand materials and participate in the SMP group activities.
- • 3. Other chronic conditions such as other autoimmune disease, neurologic, orthopedics or other systems disorder (e.g. heart, kidney) that might influence outcome assessments
- • 4. Past participation in the last year or participating in another peer-support or self-management program
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported